Are you a patient at Khaled Jabboury Md,pa already?
This clinic isn't on Cortico yet. You can still add it to your care team and securely share health records.
We update this information regularly but it can still contain outdated or incorrect info. Let us know if you notice any errors, so we may correct them. Read more
This clinic isn't on Cortico yet. You can still add it to your care team and securely share health records.
Claim this listing to update clinic details. Or learn more in demo with our team.
Dr. Khaled W. Jabboury is an oncologist in Houston, Texas, affiliated with multiple hospitals. He has been in practice for over 20 years and specializes in diagnosing and treating various types of cancer.
Map loads when you scroll here
Patients seeking oncology services, particularly those with various types of cancer, looking for a highly-rated and experienced oncologist.
The following types of medical expertise are offered in Khaled Jabboury Md,pa
Available — Call Dr. Jabboury for more information on telehealth services.
["Baylor St. Luke's Medical Center", "HCA Houston Healthcare West", "Houston Methodist Sugar Land Hospital"]
Cell proliferation kinetics of normal and tumour tissue in vitro: quiescent reproductive cells and the cycling reproductive fraction. Baker, F. L., Sanger, L. J., Rodgers, R. W., Jabboury, K., Mangini, O. R. Chemotherapy resistant sarcoma treated with whole body hyperthermia (WBH) combined with 1-3-bis(2-chloroethyl)-1-nitrosourea (BCNU) Joan M C Bull, L. H. Cronau, B. M. Newman, K. Jabboury, S. J. Allen, S. Ohno, T. Smith, A. S. Tonnesen 5-Fluorouracil rechallenge by protracted infusion in refractory breast cancer. Khaled Jabboury, Frankie A. Holmes, Gabriel N. Hortobagyi Phase II evaluation of gallium nitrate by continuous infusion in breast cancer Khaled Jabboury, Debbie Frye, Frankie A. Holmes, Giuseppe Fraschini, Gabriel N. Hortobagyi Sequential multiagent chemotherapy incorporating cisplatin, doxorubicin, and cyclophosphamide in the treatment of metastatic breast cancer Richard L. Theriault, Gabriel N. Hortobagyi, Shu W. Kau, Frankie A. Holmes, Verena Hug, Giuseppe Fraschini, Khaled Jabboury, Aman U. Buzdar Percutaneous hepatic arterial infusion of cisplatin-vinblastine for refractory breast carcinoma metastatic to the liver Giuseppe Fraschini, Chusilp Charnsangavej, C. H. Carrasco, Aman U. Buzdar, Khaled Jabboury, Gabriel N. Hortobagyi Evaluation of equipment for hyperthermic treatment of cancer Peter M. Corry, Joseph S. Kong, Elwood P. Armour, Foi J. McCraw, Tam Leduc, Khalid Jabboury Cis-diamminedichloroplatinum (II) by 5-day continuous infusion. A new dose schedule with minimal toxicity. Philip A. Salem, Maryse Khalyl, Khaled W. Jabboury, Labib Hashimi Severe Nephrotoxicity: A Probable Complication of cis-Dichlorodiammineplatinum (II) and Cephalothin-Gentamicin Therapy Philip A. Salem, Khaled W. Jabboury, Maryse F. Khalil
Phone
281-558-5558This page is part of a directory of medical practices. Cortico invests in keeping this information as up-to-date as possible, and encourages practices to manage their listings.
The directory listing is used for: